Tirzepatide, a recently approved medication, is sparking significant excitement in the medical community as a possible treatment for both diabetes, type 2 and body composition . This dual-action drug works by activating two different receptors, GLP-1 and GIP, leading to enhanced blood sugar levels and notable weight reduction in research studies .